Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The potential of big data for obstetrics discovery27
Long-acting amylin analogues for the management of obesity26
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia26
The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony22
Mouse models of type 1 diabetes and their use in skeletal research21
Use of calculated free testosterone in men: advantages and limitations20
Are diabetes microvascular complications risk factors for fragility fracture?19
Imaging techniques to study diabetic bone disease18
Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes17
Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism16
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?16
Current state of antigen-specific immunotherapy for type 1 diabetes16
Public health concerns and increased risk of severe COVID-19 disease through androgen use16
Acromegaly: achieving timely diagnosis and improving outcomes by personalized care16
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts15
The future of telehealth in type 1 diabetes15
Brief intervention of low carbohydrate dietary advice: clinic results and a review of the literature14
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases14
Optimization of assisted reproductive technology outcomes in patients with polycystic ovarian syndrome: updates and unanswered questions14
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?14
Fibrous dysplasia in children and its management13
Editorial: Endocrine disorders and body composition during childhood and adolescence13
Turner syndrome: fertility counselling in childhood and through the reproductive lifespan13
Diabetic hypertriglyceridaemia and Alzheimer's disease: causal or not?13
Can low-carbohydrate diets be recommended for reducing cardiovascular risk?13
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update13
New targets for treating hypertriglyceridemia12
Gut-derived serotonin and its emerging roles in immune function, inflammation, metabolism and the gut–brain axis12
The psychosocial impact of thyroid cancer12
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?12
Circadian rhythms and gastrointestinal hormone-related appetite regulation12
Insulin resistance and skeletal health11
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome11
Epidemiologic changes in thyroid disease11
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks11
Enteroendocrine cell differentiation and function in the intestine11
Predictors of cardiovascular risk in familial hypercholesterolemia10
Polygenic risk scores for the diagnosis and management of dyslipidemia10
Lipidomics in diabetes10
Assessing cardiovascular disease: looking beyond cholesterol9
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease9
Bone accrual in children and adolescents with type 1 diabetes: current knowledge and future directions9
Type 2 diabetes: a contemporary view from the Asian lens9
Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes9
Bridging the LatinX community care gap8
Gastrointestinal regulatory peptides8
Updates in thyroid healthcare delivery: advancing patient-centered care8
Editorial introductions7
Androgen abuse and the brain7
Effect of incretins on skeletal health7
Assisted reproductive technology outcomes and management considerations for people with epilepsy7
When history, law, and medicine intersect7
Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment7
Editorial introductions7
Surgical approaches to the adrenal gland7
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia7
The real-world applications of the symptom tracking functionality available to menstrual health tracking apps7
Integrating psychosocial and behavioral interventions into type 1 diabetes care7
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome7
Gut motility and hormone changes after bariatric procedures7
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials6
Perspectives on early health economic evaluations of RNA therapies targeted at lipoprotein(a)6
Selective progesterone receptor modulators and reproductive health6
Psychological determinants and evidence-based behavior change interventions in adherence to therapy for familial hypercholesterolemia6
Growth and development in type 1 diabetes6
Diagnostic strategies in adrenal insufficiency6
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease6
Editorial introductions6
0.10301399230957